LMO2 is a major oncogene and its ectopic expression leads to T-cell lymphoproliferative disease and T-cell acute lymphoblastic leukaemia (T-ALL) [11–13]. The gene discussed is LMO2; the disease is acute lymphoblastic leukemia.